20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid) | Trials (17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid) | Recent Studies (post-2010) (17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 39 | 6 | 33 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barden, A; Corcoran, T; Mori, TA; Phillips, M; Shinde, S | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid
| Article | Year |
|---|---|
The effects of perioperative dexamethasone on eicosanoids and mediators of inflammation resolution: A sub-study of the PADDAG trial.
Topics: Adult; Antiemetics; C-Reactive Protein; Dexamethasone; Docosahexaenoic Acids; Eicosanoids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Leukocyte Count; Leukotriene B4; Lymphocyte Count; Male; Middle Aged; Neutrophils; Perioperative Care | 2021 |